Jazz Pharmaceuticals plc

NASDAQ:JAZZ  
169.47
-1.12 (-0.66%)
4:00:00 PM EDT: $169.52 +0.05 (+0.03%)
Other Pre-Announcement

Jazz Pharmaceuticals Says 2021 Total Revenue Guidance Increased To Range Of $3.02 Billion To $3.18 Billion

Published: 06/17/2021 12:05 GMT
Jazz Pharmaceuticals plc (JAZZ) - Sees 2021 Non-GAAP Earnings per Share Between $13.40 - $14.70.
Jazz Pharmaceuticals Updates 2021 Financial Guidance to Include Recently Acquired Gw Pharmaceuticals Plc.
2021 Total Revenue Guidance Increased to a Range of $3.02 Billion to $3.18 Billion.
Sees 2021 GAAP Loss per Share Between $4.70– $2.00.
FY2021 Revenue View $3.11 Billion -- Refinitiv Ibes Data (analyst estimates).
FY2021 Earnings per Share View $15.05 -- Refinitiv Ibes Data (analyst estimates).